Home › Funds › ALETHEA CAPITAL MANAGEMENT, LLC › IMRX

ALETHEA CAPITAL MANAGEMENT, LLC position in IMRX

IMMUNEERING CORP · Health Care

ALETHEA CAPITAL MANAGEMENT, LLC reported holding 472,935 shares of IMRX (IMMUNEERING CORP) in its Q3 2026 13F filing — a position valued at US$1.9M, representing 0.99% of its reported portfolio and ranking #5 among its reported holdings. ALETHEA CAPITAL MANAGEMENT, LLC has disclosed IMRX holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)472.94K sh
Reported value held$1.94M
Portfolio Weight0.99%
First reportedQ2 2025
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How ALETHEA CAPITAL MANAGEMENT, LLC's IMRX position evolved

ALETHEA CAPITAL MANAGEMENT, LLC first disclosed a stake in IMRX in Q2 2025 at 22,935 shares (US$77K). The position peaked in Q2 2026 at 472,935 shares, worth US$2.4M. Across 6 filings, ALETHEA CAPITAL MANAGEMENT, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 472,935 shares valued at US$1.9M. Notable position changes include a 1962% increase in Q2 2026 (shares fell 18% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 22.93K $77.29K New
Q3 2025 22.93K $160.54K Hold
Q4 2025 22.93K $150.91K Hold
Q1 2026 22.93K $120.87K Hold
Q2 2026 472.94K $2.36M Add
Q3 2026 472.94K $1.94M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IMRX and 13F data

IMRX (IMMUNEERING CORP) is a Health Care company. 51 other funds we track also report a position in IMRX — the largest reported positions include Sanofi (US$11.1M), DCF Advisers, LLC (US$3.5M), Occam Crest Management LP (US$1.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IMRX

All IMRX fund holders →

FAQ

How long has ALETHEA CAPITAL MANAGEMENT, LLC held IMRX?

ALETHEA CAPITAL MANAGEMENT, LLC has disclosed IMRX holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is ALETHEA CAPITAL MANAGEMENT, LLC's current position in IMRX?

As of Q3 2026, ALETHEA CAPITAL MANAGEMENT, LLC holds 472.94K shares of IMRX (IMMUNEERING CORP), valued at $1.94M, representing 0.99% of its reported portfolio and ranking #5.

Has ALETHEA CAPITAL MANAGEMENT, LLC been buying or selling IMRX?

In the latest 13F filing (Q3 2026), ALETHEA CAPITAL MANAGEMENT, LLC held unchanged its position in IMRX. The position peaked in Q2 2026 at 472.94K shares.

Which other funds hold IMRX?

Other major institutional holders of IMRX include Sanofi, DCF Advisers, LLC, Occam Crest Management LP, among 51 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.